CareDx, Inc (FRA:1K9)
15.11
-0.13 (-0.85%)
Last updated: Dec 1, 2025, 8:11 AM CET
CareDx Revenue
CareDx had revenue of $100.06M USD in the quarter ending September 30, 2025, with 20.72% growth. This brings the company's revenue in the last twelve months to $358.00M, up 14.46% year-over-year. In the year 2024, CareDx had annual revenue of $333.79M with 19.07% growth.
Revenue (ttm)
$358.00M
Revenue Growth
+14.46%
P/S Ratio
2.49
Revenue / Employee
$550.77K
Employees
650
Market Cap
760.08M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.79M | 53.46M | 19.07% |
| Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
| Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
| Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
| Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
| Dec 31, 2019 | 127.07M | 50.50M | 65.95% |
| Dec 31, 2018 | 76.57M | 28.25M | 58.45% |
| Dec 31, 2017 | 48.32M | 7.69M | 18.93% |
| Dec 31, 2016 | 40.63M | 12.49M | 44.37% |
| Dec 31, 2015 | 28.14M | 838.00K | 3.07% |
| Dec 31, 2014 | 27.31M | 5.21M | 23.57% |
| Dec 31, 2013 | 22.10M | 1.65M | 8.05% |
| Dec 31, 2012 | 20.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
CareDx News
- 7 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Business Wire
- 7 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Wallstreet:Online
- 21 days ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 24 days ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Business Wire
- 25 days ago - CDNA: BTIG Raises Price Target to $25, Maintains Buy Rating | CDNA Stock News - GuruFocus
- 27 days ago - After-Hours Gainers: VCYT, RIGL, NPCE, CDNA, And FBLG Post Notable Moves Following Q3 Results - Nasdaq
- 27 days ago - CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance - GuruFocus